Navigation Links
Researchers Discover Breakthrough in Major Third World Scourge

Researchers at the Uniformed Services University of the Health Sciences (USU), The New Jersey Medical School (NJMS), and the U.S. Department of Agriculture// (USDA) have discovered a mechanism that provides natural protection against intestinal roundworm infections, which affect more than 1.4 billion people throughout the world, and which may lead to more effective therapies against nematode parasites.

The breakthrough research in host protection against nematode parasites was published in the August 2006 issue of the prestigious journal, Nature Medicine. The National Institutes of Health funded research was conducted at USU and NJMS by Robert M. Anthony, while a Ph.D. graduate student in USU's Molecular and Cell Biology (MCB) program, under the supervision of the principal investigator, Dr. William Gause. Dr. Joseph Urban, USDA, also collaborated on this project.

Until now, scientists have been unable to determine how the immune system mounts an effective response against tissue dwelling helminthic parasites. The findings of Drs. Anthony, Gause, and co-workers suggest a new model of resistance, involving macrophages. Macrophages have previously been associated primarily with protection against microbes, including bacteria and viruses. The studies reported in Nature Medicine indicate that during helminth infection, macrophages differentiate along an alternative activation pathway that mediates clearance of these relatively large, multicellular parasites.

Dr. Gause, formerly professor and vice chair of the Department of Microbiology and Immunology at USU, is currently university professor and senior associate dean for research at the University of Medicine and Dentistry of New Jersey-NJMS. Dr. Anthony, whose doctoral dissertation is based on this work, is now a postdoctoral fellow at Rockefeller University. Dr. Gause said that this research shows us that macrophages mediate clearance of these parasites and this insight may lead to m ore effective treatments of this important group of pathogens.



Source-Newswise
'"/>




Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers trick Alzheimers Enzyme
4. Researchers find new HIV hiding place
5. New Hair in 15 Days Could Now Be A Possibility Say Researchers
6. Researchers developed world’s smallest toothbrus
7. Researchers discover receptor cells that can cause epilepsy
8. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
9. Researchers reversed the process of memory loss
10. Researchers Identify Key Gene That May Help Brain Treatment
11. Researchers Discover Protein That Causes Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, a locally ... business owners in North Central West Virginia, is embarking on a cooperative charity ... residents in the region. , The Stepping Stones organization offers a series of ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... from the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, ... prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... announced today that it has received certification for ANSI/ASIS PSC.1-2012. The company’s work ... in environments where the rule of law has been degraded. The PSC.1 standard ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, ... a Nashville-based private equity firm, has invested $3.35 million in the company. ... and Claritas Capital offers the smart money, speed to market and accountability we ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: